Evidence-based Chinese expert recommendations on drug prevention, diagnosis,treatment,and discharge management of COVID-19 a protocol
Ying-Hui JIN1，2
Hong-Jun LI3
Qing-Yuan ZHAN4,5
Zhi-Yong PENG6,7
Yu-Feng YUAN6
Lin CAI6
Xun-Tao YIN8
Ji-Rong YUE9,10
Qi-Wen YANG11
Jian-Guang JI12
Jian XIA13
Yi-Rong LI6,14
Fu-Xiang ZHOU15
Ya-Dong GAO16
Zhui YU17
Feng XU18
Xiao-Chun ZHANG19
Ming-Li TU20
Li-Ming TAN21
Xue-Qun REN22
Min YANG23
Fang CHEN24
Xiao-Ju ZHANG25
Mei ZENG26
Yu ZHU27
Xin-Can LIU28
Jian YANG29
Dong-Chi ZHAO30
Yu-Feng DING31
Ning HOU32
Fu-Bing WANG14
Hao CHEN33
Yong-Gang ZHANG9,34
Wei LI35
Wen CHEN36
Yue-Xian SHI37
Xiu-Zhi YANG38
Xue-Jun WANG39
Yan-Jun ZHONG40
Tong DENG22
Jin-Ping GAO41
Shao-Fu YU21
Man-Ru FAN2
Hong-Yang XUE2
Lin-Xin YU2
Bing-Hui LI1,22
Lu-Yao LI22
Lin-Lu MA1
Xiang-Ying REN22,42
Na WANG22,42
Hong WENG1
Ming-Juan ZHAO1
Hao ZI1,22
Di HUANG1,2
Li-Sha LUO1,2
Qiao HUANG1,2
Yun-Yun WANG1,2
Xian-Tao ZENG1,2
Zhen-Shun CHENG6,43*
Xiao-Mei YAO44*
Xing-Huan WANG1,2,6*
Abstract：This is the protocol of updated our previously guideline named "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) ". This protocol included guideline methodology, target users, target population, conflict of interest policy, evidence searching, review and assessment, grading of evidence and recommendations development of recommendations, and updating plan. We also attached three appendices for readers: list of clinical questions, searching strategies, survey questionnaire of conflict of interest.
Keywords：2019-nCOVCOVID-19Drug preventionDiagnosisTreatmentDischarge managementClinical practice guideline
Publication Date：2020-06-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：18( 209-226 )